WEBINAR SERIES—Cardiac Research Using Microelectrode Array Technology: Methodology Considerations and Best Practices to Optimize Recording

September 21, 2022
11 a.m. EDT

Join George Portugal, PhD, of Harvard Bioscience, a developer and manufacturer of life sciences equipment headquartered in Massachusetts, for an overview of microelectrode array (MEA) technology. MEA is a valuable tool for research using stem cell-derived or primary cardiomyocytes. Networks of extracellular recording electrodes allows investigators to rapidly screen compounds, monitor for toxicological effects and study changes in conduction velocity or arrhythmia. This technology can also be applied to study changes in organoid, cardiac slice or whole heart applications. Portugal will discuss some of the methodological challenges to consider when using MEA technology for cardiac research. The discussion will include best practices to use with MEA recording and will provide examples of recording using cell culture, slice and whole heart. Together, these ­methods can optimize MEA recording and easily integrate it in the lab.

Speaker

George Portugal, PhD, is an application specialist at Harvard Bioscience, a developer and manufacturer of life sciences equipment headquartered in Massachusetts. He received his PhD in behavioral neuroscience at Temple University in Philadelphia, and was a postdoctoral scientist in the laboratory of Jose Moron-Concepcion, PhD, at Columbia University in New York. Since 2013, Portugal has worked with Multichannel Systems and HEKA Eletronik to help clients add electrophysiological techniques to their labs.